Search results

64 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
A new era for genetic interpretation
UNC Lineberger researchers are collaborating through the ClinGen consortium - a program launched to evaluate the clinical relevance of genetic variants - to help physicians make predictions about an individual’s risk of disease, develop more accurate clinical trials and design individualized treatments and care for patients.
Located in News
Shawn Ahmed
PhD, Assistant Professor, UNC-Chapel Hill, Cancer Genetics
Located in People
All the Cell’s a Stage
Brian Strahl, PhD, and his band of biochemists unravel the complicated mysteries of the epigenetic code to find a culprit in cancer development.
Located in News
Jonathan S. Berg
MD, PhD, Assistant Professor, UNC-Chapel Hill, Cancer Genetics, Cancer Genetics Program
Located in People
Scott Bultman
PhD, Assistant Professor, UNC-Chapel Hill, Cancer Genetics
Located in People
Mauro Calabrese
PhD, Assistant Professor, UNC-Chapel Hill, Cancer Genetics
Located in People
Cancer genetics the focus of UNC Lineberger symposium
UNC Lineberger's 39th annual scientific symposium was held April 8-9 at the William and Ida Friday Center for Continuing Education in Chapel Hill.
Located in News
Carolina Breast Cancer Study enrolls record 3,000 participants
The largest-ever population-based study of breast cancer in North Carolina is poised to begin the five year follow-up phase.
Located in News
Clinical Research Forum selects genomic analysis as top 10 research achievement
A cancer genomics study led by UNC Lineberger researchers and other scientists involved in The Cancer Genome Atlas (TCGA) project, a National Cancer Institute and National Human Genome Research Institute-backed effort to create a comprehensive atlas of the genetic changes in cancer, was selected as one of the top 10 clinical research achievements of the year. The project characterized molecular changes in 12 different cancers and revealed a new approach to classifying cancers.
Located in News
Ian Davis
MD, PhD, Associate Professor, UNC-Chapel Hill, Cancer Genetics, Pediatric Hematology Oncology Program, Bone and Soft Tissue Oncology Program
Located in People